Shares of Global Blood were jumping over 10% this week on news that the company has secured FDA approval for a new pill to treat sickle cell disease. Sickle cell disease is a group of disorders that affects hemoglobin, the molecule in red blood cells that delivers oxygen to cells throughout the body. It was … Continue reading “Global Blood Lands FDA Approval for Pill to Treat Sickle Cell Disease”
